We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Defines ‘Controlled Correspondence’ for Generics to Receive Timely Responses
FDA Defines ‘Controlled Correspondence’ for Generics to Receive Timely Responses
The FDA is explaining how generics firms can receive timely responses to their requests for information in a guidance that defines a new communications process known as “controlled correspondence.